BenevolentAI

BenevolentAI is a clinical-stage biopharmaceutical company based in London, UK, with additional offices in New York City and wet-lab facilities in Cambridge, UK. Founded in 2013, the company focuses on using artificial intelligence to enhance the discovery and development of new medicines for complex and untreated diseases. Their goal is to improve traditional drug development processes by reducing time and costs while increasing clinical success rates.